Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1084 of 5804
-
Robots take on tricuspid valve repair in tiny early trial
Disease control Recruiting nowValvular heart disease (VHD), caused by abnormalities in heart valves, can lead to severe complications such as heart failure and death, with approximately 220 million affected patients worldwide. The prevalence of VHD continues to grow alongside the aging global population. Tran…
Phase: NA • Sponsor: Prince of Wales Hospital, Shatin, Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New shot could tame rare bleeding disorder
Disease control Recruiting nowOpen-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of a single dose of sutacimig monotherapy in participants with congenital FVII deficiency (FVIID).
Phase: PHASE2 • Sponsor: Hemab ApS • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Could a simple blood test replace the biopsy for prostate cancer?
Diagnosis Recruiting nowThis is a single center study evaluating whether a new blood test based on platelet proteins rather than plasma proteins can improve detection of prostate cancer and evaluate the degree of serious disease. Currently, doctors rely on multiple tests such as PSA, MRI scans and biops…
Sponsor: Duke University • Aim: Diagnosis
Last updated Jun 27, 2026 11:02 UTC
-
Implantable pump fires chemo straight at pancreatic cancer
Disease control Recruiting nowThis study is being done to find out if delivering gemcitabine using the ACT-IOP-003 device directly to the area where the tumor is in the pancreas is safe and tolerable. The main questions the study aims to answer are: * Is ACT-IOP-003 safe and tolerable when given to patients…
Phase: PHASE1 • Sponsor: Continuity Biosciences, LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Blood filtering shows promise for chronic fatigue sufferers
Disease control Recruiting nowMyalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a severe, often infection-triggered disease characterized by debilitating fatigue and post-exertional malaise lasting over 14 hours, along with pain, cognitive impairment, autonomic dysfunction, and sleep disturbances…
Sponsor: Charite University, Berlin, Germany • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New daily pill shows promise for Long-Term psoriatic arthritis control
Disease control Recruiting nowPsoriatic arthritis (PsA) is a long-term inflammatory disease that affects the joints and skin. The purpose of this study is to check how safe zasocitinib is, how well it is tolerated and how well it works in adults with PsA over a longer period of time. Adults who completed th…
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Fewer hospital visits for cancer radiation? new trial tests shorter treatment
Symptom relief Recruiting nowThis study aims to evaluate a shorter course of postoperative pelvic radiotherapy in patients with cervical and endometrial cancer. The standard radiotherapy schedule usually requires many treatment sessions over several weeks, which can be burdensome for patients and may affect …
Phase: NA • Sponsor: Siriraj Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
New drug aims to restart periods in women with exercise-related amenorrhea
Disease control Recruiting nowThis study is researching an experimental drug called mibavademab (also called "study drug"). The study is focused on patients with a condition called Functional Hypothalamic Amenorrhea (FHA). FHA is a condition where a woman stops menstruating because the brain is not sending th…
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
AI blood test could spot lung cancer years earlier
Diagnosis Recruiting nowThis is a two-cohort (screen naïve vs screen established), prospective, longitudinal, single-center clinical study design that will provide data to comprehensively evaluate patient-reported outcomes of Artificial Intelligence (AI) based prediction of an individual's risk of devel…
Phase: NA • Sponsor: University of Illinois at Chicago • Aim: Diagnosis
Last updated Jun 27, 2026 12:04 UTC
-
New scan may help match breast cancer patients to the right drug
Diagnosis Recruiting nowThis study aims to evaluate whether \^68Ga-TROP2 PET/CT, combined with \^18F-FDG PET/CT, can predict the efficacy of anti-TROP2 antibody-drug conjugates in patients with advanced HER2-negative breast cancer. Baseline and dynamic imaging parameters will be used to develop predicti…
Phase: PHASE2 • Sponsor: Fudan University • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC
-
Vitamin c boost: could high doses help fight bone marrow cancer?
Disease control Recruiting nowThis is an open-label, phase II clinical trial with safety run-in evaluating the safety, tolerability, and efficacy of IV HDA in combination with azacitidine for participants with MDS.
Phase: PHASE2 • Sponsor: Prajwal Dhakal • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New hope for PCOS: supplement combo aims to restore ovulation
Disease control Recruiting nowThis study evaluates the efficacy of alpha-lipoic acid combined with myo-inositol, with or without metformin, in improving menstrual regularity and ovulation in non-diabetic women with polycystic ovary syndrome (PCOS). The study also assesses metabolic, hormonal, and clinical out…
Phase: PHASE3 • Sponsor: Beni-Suef University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New coaching program aims to delay dialysis for black kidney patients
Disease control Recruiting nowThrough the use of community-engaged processes, this project seeks to develop and implement clinical decision support (CDS) and a kidney health coaching (KHC) intervention. The CDS seeks to streamline workflows to effectively screen, identify, and link to care for those patients …
Phase: NA • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New heart surgery technique aims to prevent silent strokes
Disease control Recruiting nowTo explore surgical strategies that reduce perioperative neurologic complications in cardiovascular surgery, with the aim of improving perioperative outcomes and quality of life while reducing the socioeconomic burden. Specifically: This multicenter, randomized controlled clinic…
Phase: NA • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New pill aims to cut COPD attacks in half
Disease control Recruiting nowThis study is a multicenter, randomized, double-blind, placebo-controlled Phase II clinical trial designed to evaluate the efficacy and safety of RSS0343 tablets in patients with COPD. The study includes 3 study periods: a 4-week screening period, a 48-week treatment period, and …
Phase: PHASE2 • Sponsor: Reistone Biopharma Company Limited • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New asthma shot aims to help patients breathe easier
Disease control Not yet recruitingThis study is a phase II study of RC1416 in subjects with severe uncontrolled asthma. The purpose of the study is to evaluate efficacy and safety of RC1416 in subjects with severe uncontrolled asthma.
Phase: PHASE2 • Sponsor: Nanjing RegeneCore Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
AI reads your social media to boost breast cancer mental health
Symptom relief Not yet recruitingThis study (study type: randomized controlled trial) aims to evaluate whether a large language model-based precision emotional management intervention can improve health-related quality of life among patients with primary breast cancer. The study will enroll adult women (≥18 year…
Phase: NA • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Fetal stem cells inhaled to fight COPD?
Disease control Recruiting nowThe primary objectives are to evaluate the safety and efficacy of infusion of fully characterized clonally derived fetal mesenchymal stem cells (cfMSCs) for the control of severe symptoms associated with moderate to severe chronic obstructive pulmonary disease.
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could a simple pacemaker setting ease right heart failure?
Disease control Not yet recruitingThis study is a prospective, single-arm, target value clinical trial. We plan to prospectively enroll and follow 24 patients across three centers nationwide who have a low baseline heart rate (HR ≤ 60 bpm), meet the indication for permanent pacemaker implantation, and have right-…
Phase: NA • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New pill shows promise for Hard-to-Treat lymphoma patients
Disease control Not yet recruitingThis is a multicenter, prospective, single-arm phase II study designed to evaluate the safety and efficacy of lisaftoclax (APG-2575), an oral selective BCL-2 inhibitor, in patients with indolent B-cell lymphomas. The study will enroll adult patients with chronic lymphocytic leuke…
Phase: PHASE2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC